Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
10.32
-0.19 (-1.81%)
At close: Apr 17, 2026
SHE:301301 Market Cap
SHE:301301 has a market cap or net worth of 23.01 billion as of April 17, 2026. Its market cap has decreased by -19.52% in one year.
Market Cap
23.01B
Enterprise Value
23.49B
Revenue
4.62B
Ranking
n/a
PE Ratio
30.35
Stock Price
10.32
Market Cap Chart
Since December 27, 2022, SHE:301301's market cap has increased from 22.34B to 23.01B, an increase of 3.02%. That is a compound annual growth rate of 0.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 23.01B | 1.78% |
| Dec 31, 2025 | 22.61B | -14.39% |
| Dec 31, 2024 | 26.41B | 41.47% |
| Dec 29, 2023 | 18.67B | -6.15% |
| Dec 30, 2022 | 19.89B | -10.95% |
| Dec 27, 2022 | 22.34B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Tiantan Biological Products | 30.02B |
| Hualan Biological Engineering | 27.48B |
| Xiamen Amoytop Biotech | 26.37B |
| Suzhou Zelgen Biopharmaceuticals | 26.15B |
| BrightGene Bio-Medical Technology | 24.23B |
| Sinocelltech Group | 20.81B |
| Anhui Anke Biotechnology (Group) | 16.45B |
| Jinyu Bio-technology | 16.04B |